Clinical trials recruiting for Stage IIIB Rectal Cancer AJCC v8
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Balstilimab | 1 |
| Botensilimab | 1 |
| Capecitabine | 1 |
| Fluorouracil | 1 |
| Intensity-Modulated Radiation Therapy | 1 |
| Leucovorin | 1 |
| Oxaliplatin | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| California | 2 |
| Arizona | 1 |
| Georgia | 1 |
| Illinois | 1 |
| Oregon | 1 |
| Texas | 1 |
| Washington | 1 |
Top cities
Self-screener
Recruiting trials
- Active Surveillance and Chemotherapy Before Surgery in Treating Participants With Stage II-III Rectal Cancer
- Establishing a ctDNA Biomarker to Improve Organ Preserving Strategies in Patients With Rectal Cancer
- Neoadjuvant Botensilimab and Balstilimab for the Treatment of Advanced Resectable Colorectal Cancer NEST3
- Short Course Radiation Therapy and Combination Chemotherapy for the Treatment of Stage II-III Rectal Cancer
Related conditions
Trials recruiting for Stage IIIB Rectal Cancer AJCC v8 often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Stage IIIB Rectal Cancer AJCC v8 trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.